March 28, 2025 07:15 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India ready to offer possible assistance: PM Modi on Myanmar, Thailand earthquake | Magnitude 7.7 Earthquake hits Myanmar, strong tremors felt in Bangkok | 'Complete lawlessness': Suvendu Adhikari writes to Bengal Guv over Malda violence | 'You are a liar': Mamata Banerjee faces guests' ire over Singur, RG Kar, 'attack on Hindus' at London event | 3 cops killed, 2 terrorists shot dead during J&K's Kathua encounter: Report | Kolkata couple sues IVF centre for not revealing daughter's biological parents' identity, blames it for her death | 'India is not Dharamshala', Amit Shah says as Lok Sabha passes Immigration and Foreigners Bill 2025 | 'Now it's our turn': Vladimir Putin accepts Narendra Modi's invitation to visit India | Gold smuggling case: Kannada actor Ranya Rao’s bail plea rejected again | Congress workers clash with police in Odisha during protest against suspension of MLAs
NHRC issues notice to Delhi CS, DCGI after epilepsy drug fails quality test

NHRC issues notice to Delhi CS, DCGI after epilepsy drug fails quality test

Dec 30, 2023, at 05:24 am

New Delhi/UNI: The National Human Rights Commission (NHRC) issued notices to Delhi Chief Secretary, Drugs Controller General of India (DCGI), and Police Commissioner on Friday after the epilepsy drug ‘Sodium Valproate’ reportedly failed quality testing.

Optimus submits interim result of phase III clinical trials for Molnupiravir capsules

Optimus submits interim result of phase III clinical trials for Molnupiravir capsules

Jul 21, 2021, at 10:54 pm

Hyderabad/UNI: Optimus Pharma on Wednesday said that it has submitted the interim result of phase III clinical trials for orally administered Molnupiravir capsules on patients with mild covid infection.

Madras HC issues notice to Centre on plea to declare Covishield 'unsafe'

Madras HC issues notice to Centre on plea to declare Covishield 'unsafe'

Feb 20, 2021, at 01:53 am

Chennai/IBNS: The Madras High Court has issued a notice to the Centre over a petition to declare India's indigenous coronavirus vaccine -'Covishield'- developed by Pune-based Serum Institute as "unsafe".

Close menu